CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 387 enrolled
Drug / intervention
Piper crocatum Extract Cookie +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06676124
NCT06676124N/ACompleted

Modulation of MMP-9/NGAL Ratio in Diabetic Patients With Early Renal Dysfunction by Piper Crocatum Functional Foods

Hasanuddin University·interventional·Posted Nov 6, 2024·Updated Nov 6, 2024

In Brief

A clinical study evaluating Piper crocatum Extract Cookie and Placebo Comparator for Early Renal Dysfunction in Diabetes and 2 related conditions. Completed, enrolled 387 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to determine whether functional foods made with Piper crocatum (red betel leaf) can reduce kidney damage markers in people with diabetes who have early kidney dysfunction. Researchers aim to find out if these foods can help decrease inflammation and oxidative stress, which are known to worsen kidney problems in diabetes. Participants are divided into two groups: one group will consume cookies containing Piper crocatum extract, while the other group will consume similar cookies without the extract (placebo). They will eat these cookies twice a day for 12 weeks. This study will measure changes in two main kidney damage markers-MMP-9 and NGAL-before and after the intervention to see if Piper crocatum helps lower these markers and supports kidney health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIndonesia
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedNov 6, 2024
Enrollment StartJun 15, 2024
Primary CompletionSep 5, 2024
Study CompletionSep 16, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.7 years ago

Interventions

Piper crocatum Extract Cookiedietary

Participants in the intervention group will receive cookies containing a standardized 10% ethyl acetate extract of Piper crocatum, known for its antioxidant and anti-inflammatory properties. These cookies will be consumed twice daily for 12 weeks. The intervention aims to assess the effects of Piper crocatum on renal biomarkers, such as MMP-9 and NGAL, in diabetic patients with early renal dysfunction

Placebo Comparatordietary

Participants in the placebo group will receive cookies that are identical in appearance, taste, and texture to the active Piper crocatum cookies but do not contain the Piper crocatum extract. These cookies will be consumed twice daily for 12 weeks, serving as a control to assess the effects of the active intervention on renal biomarkers associated with diabetic nephropathy.